Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02494258
Title A Study to Evaluate Long-term Safety in Subjects With Solid Tumors and Hematological Disorders.
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Celgene
Indications

Advanced Solid Tumor

hematologic cancer

Therapies

Azacitidine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.